The company's purpose is to develop and distribute Software-as-a-Service solutions for the preparation of pharmaceutical and biological data and to provide simulation solutions. These technologies aim to explore the chemical space for medicines and reduce the failure rate in clinical trials. The company can also collect and process its own data in the laboratory. The company can establish branches and subsidiaries in Switzerland and/or abroad and participate in other companies in Switzerland and/or abroad, acquire, hold, encumber and sell real estate or intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial or other transactions that are directly or indirectly related to the company's purpose. Furthermore, the company can grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, for consideration or free of charge, and provide security of all kinds for the liabilities of such persons or group companies, including guarantees, pledges and fiduciary transfers of the company's assets. Additionally, it can operate or participate in liquidity balancing/net liquidity centralization (cash pooling) with group companies, including periodic balance adjustments (balancing), without consideration, on preferential terms, interest-free, excluding the company's intention to make a profit, and assuming cluster risks.
Outbound Leads by COHAGA